glp 1 news today glp-1 obesity drug updates New research is challenging long-held assumptions about A new wave of weight-loss

But these new results are interesting nonetheless especially for those who use oral GLP-1 medications for both weight loss and type 2 diabetes

One number may cover the clinical visit and prescription support only

Being aware of where mosquitoes breed and rest allows one to take preventive actions to eliminate their presence from those areas

Positive chronotropic and inotropic effects in heart failure have been demonstrated with infusions of GLP-1 in animal studies and small short-term studies of patients with acute heart failure post-myocardial infarction and in patients with chronic systolic and diastolic dysfunction.12 Tirzepatide has demonstrated additional benefits of slowing renal decline when used in conjunction with insulin and reduced all-cause mortality compared with other GLP-1RAs.13 In patients with type 2 diabetes mellitus (T2DM), reductions in composite renal outcomes and renal failure have been outlined in meta-analyses.14 Of great interest for gastroenterologists and hepatologists is the potential for using GLP-1 agonists in metabolic dysfunction-associated steatotic liver disease (MASLD)

Liu, PP., Xie, Y., Meng, XY

Patients should seek medical guidance promptly for severe abdominal pain, persistent vomiting, signs of dehydration, symptoms of gallbladder problems, allergic reaction symptoms, or any concerning change after starting medication